# SAM #SSDS-11-4-2026-NCIRD-ID

CDC Market Research for a California EHR Site Supporting VISION 2.0 Surveillance

**Buyer:** CDC Office of Acquisition Services
**Posted:** November 05, 2026
**Respond By:** December 04, 2026
**Identifier:** SSDS-11-4-2026-NCIRD-ID
**NAICS:** 541380, 621999, 541715, 541690

The Centers for Disease Control and Prevention is seeking market information on a California health system that can support respiratory pathogen surveillance through its VISION 2.0 network.
- **Government buyer:** Centers for Disease Control and Prevention (CDC), CDC Office of Acquisition Services; program area: National Center for Immunization and Respiratory Diseases (NCIRD). The listed contact is Debra A. Baker.
- **Requested service:** A California-based integrated health care system to serve as an electronic health record (EHR) site in CDC’s VISION 2.0 surveillance network.
  - Provide linked, longitudinal medical, laboratory, pharmacy, vaccination, immunization-registry, claims, and outcomes data across emergency and urgent care, inpatient, and intensive care settings.
  - Support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research.
- **Notable requirements:** Deliver secure, validated, standardized, analysis-ready individual-level data; collaborate on shared network protocols and quality assurance; and demonstrate relevant research and analytics capability.
  - Potential expanded work includes maternal-infant record linkage, additional COVID-19, RSV, and other pathogen data, site analyses, and participation in a network-wide scientific meeting.
- **OEMs and vendors:** No commercial OEMs, vendors, or specific products are named. No quantities or part numbers are specified.

### Description

<p>Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for <em>a California-based integrated health care system to serve as an electronic health record site in CDC&rsquo;s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings</em>. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is <em>541380-</em> <em>Testing Laboratories and Services</em>.</p>

[View original listing](https://sam.gov/opp/71915a7ca3cf474c99e2c11a87b00e75/view)